ASND
Ascendis Pharma A/S
Latest News for ASND
In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Ascendis Pharma, with a price target of $254.00. Thom......
In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on Ascendis Pharma, with a price target of $297.00. Archila cove......
By the end of this month, two pharmaceutical firms are set to receive a decision on their drug approval applications from the U.S. Food and Drug Ad......
In a report released on November 14, Derek Archila from Wells Fargo maintained a Buy rating on Ascendis Pharma, with a price target of $297.00. The......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND – Research Report) and Alkerme......
In a report released today, Maxwell Skor from Morgan Stanley maintained a Buy rating on Ascendis Pharma, with a price target of $250.00. According ......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $220.42 | +4.9% | 1.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |